The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DLH HLDGS CORP | COM | 23335Q100 | 57 | 21,977 | SH | OTR | 21,977 | 0 | 0 | ||
ECHO THERAPEUTICS INC | COM NEW | 27876L906 | 1,414 | 831,883 | SH | OTR | 831,883 | 0 | 0 | ||
INSPIREMD INC | COM NEW | 45779A309 | 7 | 24,453 | SH | OTR | 24,453 | 0 | 0 | ||
NAVIDEA BIOPHARMACEUTICALS I | COM | 63937X103 | 19,630 | 12,192,327 | SH | OTR | 12,192,327 | 0 | 0 | ||
PEDEVCO CORP | COM NEW | 70532Y204 | 1,674 | 3,719,444 | SH | OTR | 3,719,444 | 0 | 0 | ||
VIRCO MFG CO | COM | 927651109 | 125 | 43,799 | SH | OTR | 43,799 | 0 | 0 |